Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Abits Group Inc
Akanda Corp
American Rebel Holdings, Inc.
Aspire Biopharma Holdings, Inc.
Barinthus Biotherapeutics plc Sponsored ADR

Abits Group Inc

ABTS

0.00

Akanda Corp

AKAN

0.00

American Rebel Holdings, Inc.

AREB

0.00

Aspire Biopharma Holdings, Inc.

ASBP

0.00

Barinthus Biotherapeutics plc Sponsored ADR

BRNS

0.00

Shares of Qualcomm Inc (NASDAQ:QCOM) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results.

Qualcomm reported second-quarter revenue of $10.60 billion, down 2% year-over-year. The revenue total beat a Street consensus estimate of $10.59 billion according to data from Benzinga Pro. Adjusted earnings per share were $2.65 for the quarter, beating a Street consensus estimate of $2.56.

Qualcomm shares jumped 10.6% to $172.50 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Abits Group Inc (NASDAQ:ABTS) gained 46% to $1.62 in pre-market trading after the company reported a year-over-year increase in its FY25 sales results.
  • Akanda Corp (NASDAQ:AKAN) gained 33.2% to $34.65 in pre-market trading after jumping 49% on Wednesday. The U.S. Department of Justice placed state-regulated medical marijuana under Schedule III. An expedited process for broader reclassification is now underway.
  • VS Media Holdings Ltd (NASDAQ:VSME) rose 29.2% to $1.20 in pre-market trading after the investment holding company filed a Securities and Exchange Commission disclosure regarding a debt-to-equity restructuring.
  • OSR Holdings Inc (NASDAQ:OSRH) rose 28.2% to $0.59 in pre-market trading after announcing a global exclusive license agreement with Switzerland-based life sciences investment entity BCM Europe AG for its Phase 3-ready oral cancer immunotherapy, VXM01.
  • American Rebel Holdings Inc (NASDAQ:AREB) gained 25.7% to $0.50 in pre-market trading after dipping 33% on Wednesday.
  • Viavi Solutions Inc (NASDAQ:VIAV) rose 22.1% to $55.60 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates.
  • IMPINJ Inc (NASDAQ:PI) gained 20.7% to $144.91 in pre-market trading after the company reported better-than-expected first-quarter sales results and issued second-quarter guidance above estimates.
  • InMed Pharmaceuticals Inc (NASDAQ:INM) jumped 19.6% to $0.84 in pre-market trading.
  • Everspin Technologies Inc (NASDAQ:MRAM) rose 16% to $15.30 in pre-market trading after the company reported better-than-expected first-quarter financial results.

Losers

  • Inno Holdings Inc (NASDAQ:INHD) fell 31.7% to $0.082 in pre-market trading following the company’s announcement of a 1-for-20 reverse stock split aimed at maintaining compliance with Nasdaq listing requirements, particularly the minimum bid price rule.
  • Rising Dragon Acquisition (NASDAQ:RDAC) fell 26% to $15.19 in pre-market trading after jumping around 319% on Wednesday.
  • Skycorp Solar Group Ltd (NASDAQ:PN) fell 19.5% to $1.78 in pre-market trading as the company filed prospectus for offering $300 million mixed shelf.
  • Aspire Biopharma Holdings Inc (NASDAQ:ASBP) declined 12.6% to $0.21 in pre-market trading after jumping 17% on Wednesday.
  • SAGTEC GLOBAL Ltd (NASDAQ:SAGT) tumbled 12% to $1.91 in pre-market trading after jumping 28% on Wednesday. Sagtec Global posted a fourth-quarter loss of 11 cents per share.
  • Barinthus Biotherapeutics PLC – ADR (NASDAQ:BRNS) fell 11.5% to $0.53 in pre-market trading.
  • Chanson International Holding (NASDAQ:CHSN) shares dipped 11.8% to $0.029 in pre-market trading after dipping 12% on Wednesday.
  • Teladoc Health Inc (NYSE:TDOC) dipped 9.9% to $5.36 in pre-market trading after the company reported mixed first-quarter financial results.
  • Climb Global Solutions Inc (NASDAQ:CLMB) fell 8.4% to $19.50 in pre-market trading after the company reported worse-than-expected first-quarter adjusted EPS results.
  • Meta Platforms Inc (NASDAQ:META) dipped 8.2% to $613.75 in pre-market trading. Meta reported better-than-expected financial results for the first quarter on Wednesday after the bell. The company anticipates full-year capital expenditures of $125 billion to $145 billion, up from prior guidance of $115 billion to $135 billion.

Photo via Shutterstock